Gangula P R R, Thota C, Wimalawansa S J, Bukoski R D, Yallampalli C
Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas 77555, USA.
Biol Reprod. 2003 Nov;69(5):1635-41. doi: 10.1095/biolreprod.103.016725. Epub 2003 Jul 9.
Human and rodent studies have demonstrated that calcitonin gene-related peptide (CGRP), a potent vasodilator, relaxes uterine tissue during pregnancy but not during labor. The vascular sensitivity to CGRP is enhanced during pregnancy, compared to nonpregnant human uterine arteries. In the present study, we hypothesized that uterine artery relaxation effects of CGRP are enhanced in pregnant rats compared to nonpregnant diestrus rats (NP-DE) and that several secondary messenger systems are involved in this process. We also hypothesized that the expression of CGRP-A receptor components, calcitonin receptor-like receptor (CRLR), receptor activity-modifying protein (RAMP1), and CGRP-B receptors are greater in pregnant rats. For vascular relaxation studies, uterine arteries from either NP-DE or Day 18 pregnant rats were isolated, and responsiveness of the vessels to CGRP was examined with a small vessel myograph. CGRP-A and CGRP-B receptor expressions were assessed by RT-PCR and Western immunoblotting, respectively. CGRP (10(-10)--10(-7) M) produced a concentration-dependent relaxation of norepinephrine-induced contractions in both NP-DE and Day 18 pregnant rat uterine arteries. Pregnancy increased the vasodilator sensitivity to CGRP significantly (P < 0.05) compared to NP-DE rats. CGRP receptor antagonist, CGRP8-37, inhibited CGRP-induced relaxation of pregnant uterine arteries. The CGRP-induced relaxation was not affected by NG-nitro-l-arginine methyl ester (L-NAME) (nitric oxide inhibitor, 10(-4) M) but was significantly (P < 0.05) attenuated by inhibitors of guanylate cyclase (ODQ, 10(-5) M) and adenylate cyclase (SQ 22536, 10(-5) M). CGRP-induced vasorelaxation was significantly (P < 0.05) attenuated by potassium channel blockers KATP (glybenclamide, 10(-5) M) and K(CA) (tetraethylammonium, 10(-3) M). The expression of CRLR and RAMP1 was significantly (P < 0.05) elevated during pregnancy compared to nonpregnant diestrus state (NP-DE). However, CGRP-B receptor proteins in uterine arteries were not altered with pregnancy compared to those of NP-DE. These studies suggest that CGRP-induced increases in uterine artery relaxation may play a role in regulating blood flow to the uterus during pregnancy and, therefore, in fetal growth and survival.
人和啮齿动物研究表明,降钙素基因相关肽(CGRP)是一种强效血管舒张剂,在孕期可使子宫组织松弛,但在分娩时则不然。与未孕人类子宫动脉相比,孕期血管对CGRP的敏感性增强。在本研究中,我们假设与未孕动情期大鼠(NP-DE)相比,CGRP对孕鼠子宫动脉的舒张作用增强,且该过程涉及多个第二信使系统。我们还假设孕鼠中CGRP-A受体组分、降钙素受体样受体(CRLR)、受体活性修饰蛋白(RAMP1)和CGRP-B受体的表达更高。对于血管舒张研究,分离出NP-DE或妊娠第18天孕鼠的子宫动脉,并用小型血管肌动描记器检测血管对CGRP的反应性。分别通过逆转录聚合酶链反应(RT-PCR)和蛋白质免疫印迹法评估CGRP-A和CGRP-B受体的表达。CGRP(10⁻¹⁰ ~ 10⁻⁷ M)使NP-DE和妊娠第18天孕鼠子宫动脉中去甲肾上腺素诱导的收缩呈浓度依赖性舒张。与NP-DE大鼠相比,妊娠显著提高了血管对CGRP的舒张敏感性(P < 0.05)。CGRP受体拮抗剂CGRP8-37抑制CGRP诱导的孕鼠子宫动脉舒张。CGRP诱导的舒张不受NG-硝基-L-精氨酸甲酯(L-NAME,一氧化氮抑制剂,10⁻⁴ M)影响,但被鸟苷酸环化酶抑制剂(ODQ,10⁻⁵ M)和腺苷酸环化酶抑制剂(SQ 22536,10⁻⁵ M)显著减弱(P < 0.05)。CGRP诱导的血管舒张被钾通道阻滞剂KATP(格列本脲,10⁻⁵ M)和K(CA)(四乙铵,10⁻³ M)显著减弱(P < 0.05)。与未孕动情期状态(NP-DE)相比,孕期CRLR和RAMP1的表达显著升高(P < 0.05)。然而,与NP-DE相比,孕鼠子宫动脉中CGRP-B受体蛋白并未因妊娠而改变。这些研究表明,CGRP诱导的子宫动脉舒张增加可能在孕期调节子宫血流中发挥作用,进而在胎儿生长和存活中发挥作用。